FDA Approved: SUCRAID — Supplemental Application (QOL Medical, LLC)

View source ↗

Summary

The FDA approved a supplemental application for SUCRAID (sacrosidase) filed by QOL Medical LLC. The approval adds or modifies labeling for the enzyme therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Sucrase-isomaltase Deficiency

Drugs mentioned

• SUCRAID (sacrosidase)

Snippet

SUPPL AP for SUCRAID (SACROSIDASE)